 | Passage Bio (NASDAQ:PASG) Shares Down 4.8%
americanbankingnews.com - April 8 at 2:14 PM |
| Passage Bio, Inc. (NASDAQ:PASG) Receives Average Rating of "Buy" from Brokerages
americanbankingnews.com - April 8 at 5:22 AM |
| Passage Bio (NASDAQ:PASG) Trading Up 3.7%
americanbankingnews.com - April 7 at 12:30 PM |
 | Passage Bio Receives European Commission Orphan Designation for PBKR03 for Treatment of Krabbe Disease
finance.yahoo.com - April 5 at 8:31 AM |
| Amgen (NASDAQ:AMGN) & Passage Bio (NASDAQ:PASG) Financial Contrast
americanbankingnews.com - April 1 at 8:16 PM |
| Passage Bio Announces First Patient Dosed in Imagine-1 Study of PBGM01 Gene Therapy for Infantile GM1 Gangliosidosis
finance.yahoo.com - April 1 at 10:00 AM |
| Moving Average Crossover Alert: Passage Bio (PASG)
finance.yahoo.com - April 1 at 10:00 AM |
| Passage Bio to Participate in Upcoming April Investor Conferences
finance.yahoo.com - March 25 at 8:36 AM |
| Passage Bio Appoints Eliseo O. Salinas, M.D., MSc, as Chief Research & Development Officer
finance.yahoo.com - March 22 at 9:10 AM |
| U.S. Food and Drug Administration Grants Fast Track Designation to Three Passage Bio Gene Therapy Candidates Targeting Rare CNS Disorders
finance.yahoo.com - March 8 at 7:20 AM |
|
| Passage Bio Inc to Host Earnings Call
finance.yahoo.com - March 3 at 8:18 AM |
| Passage Bio Reports Fourth Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
finance.yahoo.com - March 3 at 8:18 AM |
| Passage Bio to Participate in Upcoming March Investor Conferences
finance.yahoo.com - March 2 at 7:39 PM |
 | Passage Bio, Inc. Rings the Nasdaq Stock Market Closing Bell
nasdaq.com - March 1 at 11:29 PM |
| Passage Bio, Inc. Rings the Closing Bell
nasdaq.com - March 1 at 6:29 PM |
| Passage Bio to Report Fourth Quarter and Full-Year 2020 Financial Results on March 3, 2021
finance.yahoo.com - February 24 at 7:15 AM |
| FDA Clears IND Application for Passage Bio’s Gene Therapy Candidate PBKR03 for Treatment of Patients with Early Infantile Krabbe Disease, A Rare Pediatric Disorder with No Approved Disease-Modifying Treatment Options
finance.yahoo.com - February 8 at 8:33 AM |
 | Why Guggenheim Is Bullish On Passage Bio
markets.businessinsider.com - February 4 at 1:10 PM |
| Benzinga's Top Ratings Upgrades, Downgrades For February 4, 2021
finance.yahoo.com - February 4 at 1:10 PM |
| What Type Of Shareholders Make Up Passage Bio, Inc.'s (NASDAQ:PASG) Share Registry?
finance.yahoo.com - January 28 at 9:35 AM |
| Passage Bio Receives FDA Clearance of IND Application for PBFT02 Gene Therapy Candidate for Treatment of Patients with Frontotemporal Dementia with Granulin Mutations
finance.yahoo.com - January 28 at 9:35 AM |
 | Philadelphia-area life sciences companies set to raise more than $600M in January
bizjournals.com - January 22 at 2:53 PM |
| Here's Why Shares of Passage Bio Dropped Today
finance.yahoo.com - January 22 at 2:53 PM |
| Passage Bio Announces Pricing of Public Offering
finance.yahoo.com - January 21 at 11:29 PM |
| Passage Bio to Host First of a Series of 2021 Virtual R&D Events on January 25
finance.yahoo.com - January 19 at 5:35 PM |
| Passage Bio Announces Launch of Proposed Public Offering
finance.yahoo.com - January 19 at 5:35 PM |
| NVTA Jan 2023 70.000 put
in.finance.yahoo.com - January 7 at 12:56 AM |
| Passage Bio to Present at the 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 7:10 PM |
| NVTA Jan 2022 5.000 put
in.finance.yahoo.com - January 1 at 11:52 PM |
| 2020 in Review: Philadelphia-area drug developers dazzle Wall Street in big year for IPOs
bizjournals.com - December 23 at 2:06 PM |
|
| Philadelphia gene therapy firm Passage Bio signs lease deal for lab space in New Jersey
bizjournals.com - December 17 at 3:04 PM |
| Passage Bio Announces Gene Therapy Manufacturing Research and Development Site
finance.yahoo.com - December 16 at 9:25 AM |
| Is PASG A Good Stock To Buy Now?
finance.yahoo.com - December 15 at 11:59 PM |
| Passage Bio Teams with Catalent to Start CGMP Manufacturing for Lead Gene Therapy Products
finance.yahoo.com - December 7 at 7:32 AM |
| Passage Bio (NASDAQ:PASG) Is In A Good Position To Deliver On Growth Plans
finance.yahoo.com - November 24 at 2:03 PM |
| Passage Bio to Present at Piper Sandler 32nd Annual Healthcare Conference
finance.yahoo.com - November 23 at 6:00 PM |
 | Passage Bio Highlights University of Pennsylvania's Gene Therapy Program's Newly Published Research to Prevent Toxicity Associated with Gene Therapy
benzinga.com - November 11 at 5:49 PM |
| Passage Bio Highlights University of Pennsylvania’s Gene Therapy Program’s Newly Published Research to Prevent Toxicity Associated with Gene Therapy
finance.yahoo.com - November 11 at 5:49 PM |
| Passage Bio to Participate in Upcoming November Investor Conferences
finance.yahoo.com - November 11 at 7:46 AM |
| Passage Bio and Invitae Announce Collaboration to Facilitate Genetic Testing to Support Early Diagnosis and Greater Awareness of Clinical Trials for Patients with GM1
finance.yahoo.com - November 9 at 8:05 AM |
| Passage Bio to Report Third Quarter 2020 Financial Results on November 10, 2020
finance.yahoo.com - November 4 at 9:59 AM |
| FDA grants two key designations to Passage Bio's experimental Krabbe disease therapy
bizjournals.com - October 28 at 5:25 PM |
 | Passage Bio’s PBKR03 nabs Orphan drug tag and accelerated review status for Krabbe disease
seekingalpha.com - October 28 at 7:23 AM |
| Passage Bio’s PBKR03 Receives Orphan Drug and Rare Pediatric Disease Designations from FDA for Treatment of Krabbe Disease
finance.yahoo.com - October 28 at 7:23 AM |
| Passage Bio's lead gene therapy an Orphan Drug in Europe for rare nerve cell disease
seekingalpha.com - October 26 at 12:49 PM |
| Passage Bio’s PBGM01 Receives Orphan Drug Designation from EMA for Treatment of GM1 Gangliosidosis
finance.yahoo.com - October 26 at 7:48 AM |
| Passage Bio (PASG) Looks Good: Stock Adds 5.4% in Session
nasdaq.com - October 14 at 2:12 PM |
| Passage Bio's PBGM01 shows encouraging pre-clinical benefits in murine model of GM1 gangliosidosis
seekingalpha.com - October 14 at 9:12 AM |
 | PASG.OQ - Passage Bio Inc Profile | Reuters
reuters.com - October 3 at 2:28 PM |
| Passage Bio to Participate in Citi’s 15th Annual BioPharma Virtual Conference
finance.yahoo.com - September 3 at 8:09 AM |
